Exfoliative dermatitis
☆ Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo.
Red (burning) Skin Syndrome ― Erythema ati iwọn lori gbogbo ara jẹ awọn aami aisan akọkọ ti Exfoliative dermatitis.
References
Erythroderma jẹ ipo awọ to ṣọwọn ṣugbọn pataki. Lakoko ti o jẹ idi gangan ti a ko mọ nigbagbogbo, o le jẹ okunfa nipasẹ iṣesi oogun tabi akàn ti o wa labẹ. Ọkan akàn ti o wọpọ ti o sopọ mọ dermatitis exfoliative jẹ lymphoma T-cell ti o ni awọ, eyiti o le ma ṣe afihan awọn aami aisan fun awọn osu tabi paapaa awọn ọdun lẹhin ti ipo awọ ara bẹrẹ. Nigbagbogbo, ile-iwosan nilo fun ayẹwo akọkọ ati itọju. Awọn alaisan ti o ni arun ti o fa oogun ni gbogbogbo ni iwoye igba pipẹ to dara, botilẹjẹpe awọn ọran laisi idi ti o han gbangba ṣọ lati ni iṣẹ-ṣiṣe loorekoore ati gbigbemi. Asọtẹlẹ fun awọn ọran ti o sopọ mọ akàn ni igbagbogbo da lori bii alakan naa ṣe nlọsiwaju.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Nigbagbogbo o ṣe afihan pupa ti o tan kaakiri ati ibora ti o ju 90% ti ara lọ. Ipo yii jẹ ami ti o han ti ọpọlọpọ awọn ọran ilera abẹlẹ bi psoriasis, àléfọ, tabi idahun si awọn oogun kan.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Idi ti o wọpọ julọ ti erythroderma jẹ ilọsiwaju ti arun awọ ara, gẹgẹbi psoriasis, olubasọrọ dermatitis, seborrheic dermatitis, lichen planus, pityriasis rubra pilaris tabi iṣesi oogun, gẹgẹbi lilo awọn sitẹriọdu ti agbegbe. Iṣe eniyan alakọbẹrẹ kere loorekoore ati pe a maa n rii ni awọn ọran ti lymphoma T-cell awọ-ara. Nitoripe o ṣe pataki lati ṣe iyatọ rẹ lati awọ-ara T cell lymphoma, a ṣe biopsy kan.